Francois Brisebois
Stock Analyst at LifeSci Capital
(3.72)
# 2,150
Out of 4,444 analysts
364
Total ratings
41.4%
Success rate
4.5%
Average return
Main Sectors:
Stocks Rated by Francois Brisebois
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics | Reiterated: Buy | $9 | $4.20 | +114.54% | 17 | Jun 25, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $44 | $20.60 | +113.59% | 29 | Jun 24, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $731 | $315.08 | +132.00% | 28 | Jun 23, 2026 | |
| MPLT MapLight Therapeutics | Reiterated: Buy | $45 | $31.15 | +44.46% | 2 | Jun 23, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $44 → $63 | $45.64 | +38.04% | 26 | Jun 22, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $10 | $3.67 | +172.55% | 9 | Jun 17, 2026 | |
| SVRA Savara | Reiterated: Buy | $10 | $5.83 | +71.53% | 31 | Jun 9, 2026 | |
| CMPS COMPASS Pathways | Reiterated: Buy | $23 | $13.51 | +70.24% | 14 | Jun 2, 2026 | |
| LRMR Larimar Therapeutics | Rated: Buy | $25 | $3.58 | +598.32% | 6 | May 16, 2026 | |
| OVID Ovid Therapeutics | Maintained: Buy | $5 | $2.41 | +107.90% | 14 | May 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $95 | $64.89 | +46.40% | 28 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.75 | - | 27 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $34.10 | n/a | 15 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $18.15 | n/a | 27 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $80 | $23.70 | n/a | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $5.64 | n/a | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.82 | n/a | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $30 | $7.23 | n/a | 3 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $5.88 | n/a | 14 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.90 | n/a | 1 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.03 | n/a | 11 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $14.53 | n/a | 7 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $6.19 | n/a | 12 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $20 | $1.14 | n/a | 3 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $60 | $1.92 | n/a | 4 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.81 | n/a | 4 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $100 | $0.00001 | n/a | 2 | Sep 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.4511 | n/a | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $96.93 | n/a | 1 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.5778 | n/a | 1 | Feb 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8.5 → $4 | $1.13 | n/a | 2 | Sep 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $72 | $7.90 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $15 | $0.003 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $1 | $0.11 | n/a | 4 | Aug 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $1 | $1.12 | n/a | 2 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $50 | $1.50 | n/a | 1 | Jun 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $0.751 | n/a | 1 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $2.48 | n/a | 1 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $0.05305 | n/a | 1 | Feb 13, 2018 |
Aquestive Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: $9
Current: $4.20
Upside: +114.54%
Dyne Therapeutics
Jun 24, 2026
Reiterated: Buy
Price Target: $44
Current: $20.60
Upside: +113.59%
Praxis Precision Medicines
Jun 23, 2026
Reiterated: Buy
Price Target: $731
Current: $315.08
Upside: +132.00%
MapLight Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $45
Current: $31.15
Upside: +44.46%
Definium Therapeutics
Jun 22, 2026
Reiterated: Buy
Price Target: $44 → $63
Current: $45.64
Upside: +38.04%
Opus Genetics
Jun 17, 2026
Reiterated: Buy
Price Target: $10
Current: $3.67
Upside: +172.55%
Savara
Jun 9, 2026
Reiterated: Buy
Price Target: $10
Current: $5.83
Upside: +71.53%
COMPASS Pathways
Jun 2, 2026
Reiterated: Buy
Price Target: $23
Current: $13.51
Upside: +70.24%
Larimar Therapeutics
May 16, 2026
Rated: Buy
Price Target: $25
Current: $3.58
Upside: +598.32%
Ovid Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $5
Current: $2.41
Upside: +107.90%
May 9, 2026
Rated: Buy
Price Target: $95
Current: $64.89
Upside: +46.40%
Oct 24, 2025
Rated: Hold
Price Target: n/a
Current: $2.75
Upside: -
Apr 8, 2025
Reiterated: Buy
Price Target: $61
Current: $34.10
Upside: n/a
Apr 4, 2025
Reiterated: Buy
Price Target: $65
Current: $18.15
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $4 → $80
Current: $23.70
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $16
Current: $5.64
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $12
Current: $1.82
Upside: n/a
Feb 28, 2025
Reiterated: Buy
Price Target: $28 → $30
Current: $7.23
Upside: n/a
Jan 8, 2025
Reiterated: Buy
Price Target: $11
Current: $5.88
Upside: n/a
Aug 26, 2024
Rated: Hold
Price Target: n/a
Current: $9.90
Upside: n/a
Aug 26, 2024
Rated: Hold
Price Target: n/a
Current: $6.03
Upside: n/a
Jul 29, 2024
Maintained: Buy
Price Target: $36
Current: $14.53
Upside: n/a
Jul 1, 2024
Reiterated: Buy
Price Target: $6
Current: $6.19
Upside: n/a
Aug 17, 2023
Maintained: Buy
Price Target: $90 → $20
Current: $1.14
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $8 → $60
Current: $1.92
Upside: n/a
Mar 23, 2023
Maintained: Buy
Price Target: $5
Current: $1.81
Upside: n/a
Sep 27, 2022
Maintained: Buy
Price Target: $80 → $100
Current: $0.00001
Upside: n/a
Jul 18, 2022
Initiated Coverage: Buy
Price Target: $18
Current: $0.4511
Upside: n/a
May 11, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $96.93
Upside: n/a
Feb 4, 2020
Initiated Coverage: Buy
Price Target: $18
Current: $0.5778
Upside: n/a
Sep 10, 2019
Maintained: Buy
Price Target: $8.5 → $4
Current: $1.13
Upside: n/a
Sep 4, 2019
Maintained: Buy
Price Target: $68 → $72
Current: $7.90
Upside: n/a
Sep 4, 2019
Maintained: Buy
Price Target: $23 → $15
Current: $0.003
Upside: n/a
Aug 22, 2019
Maintained: Hold
Price Target: $2 → $1
Current: $0.11
Upside: n/a
Jul 29, 2019
Maintained: Hold
Price Target: $1.5 → $1
Current: $1.12
Upside: n/a
Jun 27, 2019
Upgraded: Buy
Price Target: $50
Current: $1.50
Upside: n/a
Feb 20, 2019
Maintained: Buy
Price Target: $11
Current: $0.751
Upside: n/a
May 24, 2018
Reiterated: Buy
Price Target: $26
Current: $2.48
Upside: n/a
Feb 13, 2018
Maintained: Buy
Price Target: $210
Current: $0.05305
Upside: n/a